Heron Neutron Medical Corp. (7799.TW) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan

Price
439.50 TWD
Market cap
69.23 bn TWD
P/E (2025)
–
P/S (2025)
6,715.81
Dividend yield
0.00 %
Net margin
-4,672.74 %
Return on equity (ROE)
-4.19 %
Return on assets (ROA)
-4.16 %

Heron Neutron Medical Corp. financials

Fiscal year20242025
Revenue0.00 TWD10.31 m TWD
Gross profit-3.59 m TWD-25.78 m TWD
Operating income-259.00 m TWD-534.32 m TWD
EBIT-259.89 m TWD-480.78 m TWD
Net income-260.08 m TWD-481.67 m TWD
Diluted EPS – continuing operations-1.85 TWD-3.06 TWD

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Heron Neutron Medical Corp.

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.